M. Sbacchi

874 total citations
33 papers, 726 citations indexed

About

M. Sbacchi is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, M. Sbacchi has authored 33 papers receiving a total of 726 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cellular and Molecular Neuroscience, 20 papers in Molecular Biology and 9 papers in Physiology. Recurrent topics in M. Sbacchi's work include Neuropeptides and Animal Physiology (20 papers), Receptor Mechanisms and Signaling (14 papers) and Pharmacological Receptor Mechanisms and Effects (11 papers). M. Sbacchi is often cited by papers focused on Neuropeptides and Animal Physiology (20 papers), Receptor Mechanisms and Signaling (14 papers) and Pharmacological Receptor Mechanisms and Effects (11 papers). M. Sbacchi collaborates with scholars based in Italy, United States and Germany. M. Sbacchi's co-authors include Giuseppe Petrone, Paola Petrillo, Giuseppe Giardina, Mark A. Scheideler, Paola Zaratin, Martine Garnier, Alessandra Tavani, Giulio Dondio, Vittorio Vecchietti and Claudia Fossati and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

M. Sbacchi

33 papers receiving 701 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Sbacchi Italy 14 470 464 173 115 39 33 726
Barry Kenny United Kingdom 12 595 1.3× 324 0.7× 154 0.9× 62 0.5× 27 0.7× 19 951
Peter J. Gengo United States 15 570 1.2× 338 0.7× 124 0.7× 79 0.7× 19 0.5× 23 832
Masakatsu Nozaki Japan 13 330 0.7× 278 0.6× 96 0.6× 76 0.7× 41 1.1× 68 666
F Lefèvre-Borg France 18 398 0.8× 300 0.6× 193 1.1× 74 0.6× 16 0.4× 28 821
Michio Terai United Kingdom 11 362 0.8× 240 0.5× 99 0.6× 75 0.7× 27 0.7× 24 613
Masahiro Suno Japan 18 428 0.9× 231 0.5× 133 0.8× 80 0.7× 13 0.3× 31 759
Robert W. McNutt United States 18 892 1.9× 867 1.9× 306 1.8× 199 1.7× 38 1.0× 29 1.3k
Peter Ström Sweden 13 313 0.7× 349 0.8× 214 1.2× 69 0.6× 19 0.5× 23 772
Bernard Levet‐Trafit Switzerland 9 379 0.8× 273 0.6× 115 0.7× 142 1.2× 49 1.3× 9 727
Kathryn W. Schenck United States 13 314 0.7× 238 0.5× 200 1.2× 75 0.7× 24 0.6× 25 672

Countries citing papers authored by M. Sbacchi

Since Specialization
Citations

This map shows the geographic impact of M. Sbacchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Sbacchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Sbacchi more than expected).

Fields of papers citing papers by M. Sbacchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Sbacchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Sbacchi. The network helps show where M. Sbacchi may publish in the future.

Co-authorship network of co-authors of M. Sbacchi

This figure shows the co-authorship network connecting the top 25 collaborators of M. Sbacchi. A scholar is included among the top collaborators of M. Sbacchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Sbacchi. M. Sbacchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zaratin, Paola, Giuseppe Petrone, M. Sbacchi, et al.. (2004). Modification of Nociception and Morphine Tolerance by the Selective Opiate Receptor-Like Orphan Receptor Antagonist (–)-cis-1-Methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8,9-tetrahydro-5 H-benzocyclohepten-5-ol (SB-612111). Journal of Pharmacology and Experimental Therapeutics. 308(2). 454–461. 131 indexed citations
3.
Verotta, Luisellá, et al.. (2002). Synthesis and antinociceptive activity of chimonanthines and pyrrolidinoindoline-Type alkaloids. Bioorganic & Medicinal Chemistry. 10(7). 2133–2142. 62 indexed citations
5.
Collina, Simona, Ornella Azzolina, M. Sbacchi, et al.. (2000). Synthesis and antinociceptive activity of pyrrolidinylnaphthalenes. Bioorganic & Medicinal Chemistry. 8(8). 1925–1930. 10 indexed citations
6.
Giardina, Giuseppe, et al.. (1994). Selective .kappa.-Opioid Agonists: Synthesis and Structure-Activity Relationships of Piperidines Incorporating an Oxo-Containing Acyl Group. Journal of Medicinal Chemistry. 37(21). 3482–3491. 24 indexed citations
7.
Wang, Yixin, Geoffrey D. Clarke, M. Sbacchi, Giuseppe Petrone, & David P. Brooks. (1994). Contribution of alpha-2 adrenoceptors to kappa opioid agonist-induced water diuresis in the rat.. Journal of Pharmacology and Experimental Therapeutics. 270(1). 244–249. 17 indexed citations
8.
Vecchietti, Vittorio, Geoffrey D. Clarke, Giulio Dondio, et al.. (1992). Substituted 1-(aminomethyl)-2-(arylacetyl)-1,2,3,4-tetrahydroisoquinolines: a novel class of very potent antinociceptive agents with varying degrees of selectivity for .kappa. and .mu. opioid receptors. Journal of Medicinal Chemistry. 35(16). 2970–2978. 20 indexed citations
9.
Clarke, Geoffrey D., Giulio Dondio, Giuseppe Giardina, et al.. (1992). Enantiospecificity of kappa receptors: Comparison of racemic compounds and active enantiomers in two novel series of kappa agonist analgesics. Chirality. 4(1). 8–15. 3 indexed citations
10.
Petrillo, Paola, Jan Kowalski, M. Sbacchi, & Alessandra Tavani. (1992). Characterization of Opioid Binding Sites in Rat Spinal Cord. Journal of Receptor Research. 12(1). 39–57. 3 indexed citations
11.
Vecchietti, Vittorio, G. D. Clarke, Renato Colle, et al.. (1991). (1S)-1-(Aminomethyl)-2-(arylacetyl)-1,2,3,4-tetrahydroisoquinoline and heterocycle-condensed tetrahydropyridine derivatives: members of a novel class of very potent .kappa. opioid analgesics. Journal of Medicinal Chemistry. 34(8). 2624–2633. 52 indexed citations
12.
Tavani, Alessandra, et al.. (1989). Distribution of μ-, δ- and k-opioid binding sites in membrane suspensions from rabbit brain regions. Journal of Endocrinological Investigation. 12(10). 1–4. 3 indexed citations
13.
Petrillo, Paola, et al.. (1989). Regional variations in binding capacities at μ-, δ- and κ-opioid sites in membrane suspensions from rabbit brain. European Journal of Pharmacology. 166(2). 213–217. 6 indexed citations
14.
Petrillo, Paola, et al.. (1988). Interaction of U-69,593 with μ-, ∂- and k-opioid binding sites and its analgesic and intestinal effects in rats. Life Sciences. 42(3). 293–301. 31 indexed citations
16.
Esposito, Emanuela, Luigi Cervo, Paola Petrillo, et al.. (1987). Dopamine denervation of the nucleus accumbens induces a selective increase in the number of δ-opioid binding sites. Brain Research. 436(1). 25–29. 12 indexed citations
17.
Bassi, S., et al.. (1986). Treatment of Parkinson's disease with orphenadrine alone and in combination with L‐dopa. International Journal of Clinical Practice. 40(7). 273–275. 8 indexed citations
18.
Bassi, S., et al.. (1984). Chronic Cerebrovascular Disorders: A Clinical Study with Cyclandelate. International Journal of Clinical Practice. 38(10). 344–349. 5 indexed citations
19.
Sbacchi, M., et al.. (1984). Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders.. PubMed. 34. 69–73. 1 indexed citations
20.
Bassi, S., et al.. (1984). Double‐blind evaluation of monosialoganglioside (GM1) therapy in stroke. Journal of Neuroscience Research. 12(2-3). 493–498. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026